These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 4465730)
41. Treatment of insulin lipoatrophy with monocomponent insulin. Teuscher A Diabetologia; 1974 Jun; 10(3):211-4. PubMed ID: 4845721 [No Abstract] [Full Text] [Related]
42. [Clinical problems of antibody formation in insulin therapy]. Nakagawa M Horumon To Rinsho; 1972 May; 20(5):353-6. PubMed ID: 4560269 [No Abstract] [Full Text] [Related]
43. Insulin antibodies induced by bovine insulin therapy. Reeves WG; Kelly U Clin Exp Immunol; 1982 Oct; 50(1):163-70. PubMed ID: 6756728 [TBL] [Abstract][Full Text] [Related]
44. Pork vs. beef insulin in control of diabetes mellitus--a case study. Cohen SS Am J Hosp Pharm; 1972 Oct; 29(10):874-6. PubMed ID: 4672658 [No Abstract] [Full Text] [Related]
45. Insulin antibody formation. I. The influence of age, sex, infections, insulin dosage and regulation of diabetes. Andersen OO Acta Endocrinol (Copenh); 1972 Sep; 71(1):126-40. PubMed ID: 4678008 [No Abstract] [Full Text] [Related]
46. [Proceedings: Formation of anti-insulin antibodies IgG in diabetic patients treated with conventional insulin monocomposed or monospecific]. Weber HU; Sourisseau D; Zahnd GR Helv Med Acta; 1974 May; 37(5-6):367. PubMed ID: 4410557 [No Abstract] [Full Text] [Related]
48. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038 [TBL] [Abstract][Full Text] [Related]
49. [Insulin lipoatrophy and its elimination through the use of monocomponent insulin]. Maaz E Z Gesamte Inn Med; 1976 Nov; 31(22):941-5. PubMed ID: 1035452 [TBL] [Abstract][Full Text] [Related]
50. [Effect of monocomponent insulin serum anti-insulin antibody levels (author's transl)]. García de los Ríos M; Mella I; Durruty P; Ruiz F; López G; Tapia JC; González G Rev Med Chil; 1981 Jun; 109(6):509-15. PubMed ID: 7036310 [No Abstract] [Full Text] [Related]
51. [Clinical and experimental studies on insulin antibodies]. Sato H Igaku Kenkyu; 1968 Feb; 38(2):256-76. PubMed ID: 4878094 [No Abstract] [Full Text] [Related]
52. Immunopathology of insulin. Clinical and experimental studies. Federlin K Monogr Endocrinol; 1971; 6():1-185. PubMed ID: 4949996 [No Abstract] [Full Text] [Related]
53. [Immunopathology of diabetes mellitus. Experimental studies on the anti-insulin-serum-diabetes]. Freytag GH Veroff Morphol Pathol; 1972; 88():1-101. PubMed ID: 5022996 [No Abstract] [Full Text] [Related]
55. Behaviour of insulin antibodies in diabetics treated with different insulins. Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044 [TBL] [Abstract][Full Text] [Related]
56. High and low affinity insulin antibodies. Kerp L; Kasemir H Acta Endocrinol Suppl (Copenh); 1976; 205():211-22. PubMed ID: 1087091 [No Abstract] [Full Text] [Related]
57. [ELISA detection of protamine antibodies]. Junker M; Hobler H; Federlin K Immun Infekt; 1985 Apr; 13(2):80-2. PubMed ID: 3888823 [TBL] [Abstract][Full Text] [Related]
58. Monocomponent insulin in maturity onset diabetes mellitus. Viswanathan M; Ramachandran A; Snehalatha C; Viswanathan M J Indian Med Assoc; 1981 Mar; 76(5):73-5. PubMed ID: 7021694 [No Abstract] [Full Text] [Related]
59. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin]. Iavicoli M; Di Mario U; Coronel GA; Musacchio N; Arduini P Minerva Endocrinol; 1984; 9(2):115-20. PubMed ID: 6390124 [No Abstract] [Full Text] [Related]
60. [Comparison of the action of zinc-protamine insulin of bovine and porcine origin]. Malczewski B; Rojszyk E Wiad Lek; 1971 Apr; 24(7):619-22. PubMed ID: 5103478 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]